By 2025, the clinical use of cannabis for inflammation is expected to see significant changes. Researchers anticipate refined delivery methods, potentially featuring innovative cannabinoid mixtures and localized routes of delivery, will arise. While existing data stays preliminary, future trials focusing on particular forms of inflammation – like